MEETINGS - Portable Inhalers (UK) December 1997:
This article was originally published in Clinica
Management Forum will hold its sixth annual conference on Portable Inhalers in London on December 9-10. Key issues to be covered include an update on MDI re-formulation; bioequivalence of non-CFC formulations; the psychology of non-compliance; designing for compliance and ease of use; future prospects of dry powder inhalers; and new approaches to inhalation systems. For more information contact Management Forum in the UK. Tel: +44 1483 570099. Fax: +44 1483 536 424.
You may also be interested in...
Perrigo, Pfizer want the US FDA to postpone its March 1 deadline for conducting nitrosamine risk assessments. Generics exec cites“serious compliance challenges” in conducting these assessments due to difficulty in finding the right lab equipment necessary to quantify nitrosamine daily intake limits.
Deal snapshot: For $425m up front, the pharma obtains a Phase III recombination fusion protein that shows ability to improve hospitalized patients’ clinical status and reduce risk of death.
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.